Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thymoma 1 Thymic epithelial tumor 1 Neoplasm, Residual 1 Hodgkin Disease 1 Colorectal Neoplasms 1

Interventions

fludarabine 2 Cyclophosphamide 2 avelumab 1 Nivolumab 1 AP 1903 reagent 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Thymoma × AP 1903 reagent × 30 days × Clear all

NCT07598955 2026-05-20

SELECT-NK-THYM

Beijing Biotech

Phase 1/2 Recruiting

Thymic epithelial tumor, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡